Cargando…

Analysis of Omics Data Reveals Nucleotide Excision Repair-Related Genes Signature in Highly-Grade Serous Ovarian Cancer to Predict Prognosis

Most of the high-grade serous ovarian cancers (HGSOC) are accompanied by P53 mutations, which are related to the nucleotide excision repair (NER) pathway. This study aims to construct a risk signature based on NER-related genes that could effectively predict the prognosis for advanced patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dai, Danian, Li, Qiang, Zhou, Pengfei, Huang, Jianjiang, Zhuang, Hongkai, Wu, Hongmei, Chen, Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9235032/ https://www.ncbi.nlm.nih.gov/pubmed/35769257 http://dx.doi.org/10.3389/fcell.2022.874588

Ejemplares similares

Epigenetic Regulation of Nucleotide Excision Repair
por: Li, Wentao, et al.
Publicado: (2022)

Fallopian tube secreted protein affects ovarian metabolites in high grade serous ovarian cancer
por: Bergsten, Tova M., et al.
Publicado: (2022)

USP44 Stabilizes DDB2 to Facilitate Nucleotide Excision Repair and Prevent Tumors
por: Zhang, Ying, et al.
Publicado: (2021)

Methods to Study Intracellular Movement and Localization of the Nucleotide Excision Repair Proteins at the DNA Lesions in Mammalian Cells
por: Robu, Mihaela, et al.
Publicado: (2020)

RHOAming Through the Nucleotide Excision Repair Pathway as a Mechanism of Cellular Response Against the Effects of UV Radiation
por: Magalhaes, Yuli T., et al.
Publicado: (2020)

Transcriptome analyses reveal new insights on key determinants of perineural invasion in high-grade serous ovarian cancer
por: Zheng, Zhen, et al.
Publicado: (2023)

The Base Excision Repair Pathway in the Nematode Caenorhabditis elegans
por: Elsakrmy, Noha, et al.
Publicado: (2020)

Nucleotide Excision Repair and Transcription-coupled DNA Repair Abrogate the Impact of DNA Damage on Transcription
por: Nadkarni, Aditi, et al.
Publicado: (2016)

Multi-Omics Signatures Identification for LUAD Prognosis Prediction Model Based on the Integrative Analysis of Immune and Hypoxia Signals
por: Lou, Yuqing, et al.
Publicado: (2022)

Multi-Omics Prognostic Signatures Based on Lipid Metabolism for Colorectal Cancer
por: Sun, YuanLin, et al.
Publicado: (2022)

Multi-Omics Analysis of Anlotinib in Pancreatic Cancer and Development of an Anlotinib-Related Prognostic Signature
por: Zhang, Xi, et al.
Publicado: (2021)

Metabolic Signature-Based Subtypes May Pave Novel Ways for Low-Grade Glioma Prognosis and Therapy
por: Li, Ganglei, et al.
Publicado: (2021)

Multi-Omics Data Integration Analysis of an Immune-Related Gene Signature in LGG Patients With Epilepsy
por: Cheng, Quan, et al.
Publicado: (2021)

Nucleotide excision repair: a versatile and smart toolkit: Nucleotide excision repair
por: Zhang, Xiping, et al.
Publicado: (2022)

Integrated Analysis of Ferroptosis-Related Biomarker Signatures to Improve the Diagnosis and Prognosis Prediction of Ovarian Cancer
por: Wang, Huan, et al.
Publicado: (2022)

Multi-Omics Analysis of Novel Signature for Immunotherapy Response and Tumor Microenvironment Regulation Patterns in Urothelial Cancer
por: Chu, Guangdi, et al.
Publicado: (2021)

Development and Validation of a Novel Histone Acetylation-Related Gene Signature for Predicting the Prognosis of Ovarian Cancer
por: Dai, Qinjin, et al.
Publicado: (2022)

Deficiency of nucleotide excision repair is associated with mutational signature observed in cancer
por: Jager, Myrthe, et al.
Publicado: (2019)

Role of Base Excision Repair Pathway in the Processing of Complex DNA Damage Generated by Oxidative Stress and Anticancer Drugs
por: Baiken, Yeldar, et al.
Publicado: (2021)

Prognostic gene expression signature for high-grade serous ovarian cancer
por: Millstein, J., et al.
Publicado: (2020)

Single-cell and genetic multi-omics analysis combined with experiments confirmed the signature and potential targets of cuproptosis in hepatocellular carcinoma
por: Cao, Feng, et al.
Publicado: (2023)

Classification of High-Grade Serous Ovarian Carcinoma by Epithelial-to-Mesenchymal Transition Signature and Homologous Recombination Repair Genes
por: Sohn, Min-Hwan, et al.
Publicado: (2021)

The association of polymorphisms in nucleotide excision repair genes with ovarian cancer susceptibility
por: Zhao, Zhiguang, et al.
Publicado: (2018)

Identify Function of WASL in Prognosis of Cervical Cancer Based on Omics Data
por: Hou, Jinxuan, et al.
Publicado: (2021)

An Immune Panel Signature Predicts Prognosis of Lung Adenocarcinoma Patients and Correlates With Immune Microenvironment
por: Zhou, Yuan, et al.
Publicado: (2021)

A novel prognostic 7-methylguanosine signature reflects immune microenvironment and alternative splicing in glioma based on multi-omics analysis
por: Wang, Zihan, et al.
Publicado: (2022)

Identification of the Immune Signatures for Ovarian Cancer Based on the Tumor Immune Microenvironment Genes
por: Shen, Xiaoyan, et al.
Publicado: (2022)

Genomic Rearrangement Signatures and Clinical Outcomes in High-Grade Serous Ovarian Cancer
por: Hillman, R Tyler, et al.
Publicado: (2017)

Immune Infiltration-Related Signature Predicts Risk Stratification and Immunotherapy Efficacy in Grade II and III Gliomas
por: Luo, Cong, et al.
Publicado: (2021)

Metabolism-Associated DNA Methylation Signature Stratifies Lower-Grade Glioma Patients and Predicts Response to Immunotherapy
por: Yang, Guozheng, et al.
Publicado: (2022)

Nomograms to Predict the Density of Tumor-Infiltrating Lymphocytes in Patients With High-Grade Serous Ovarian Cancer
por: Dai, Danian, et al.
Publicado: (2021)

Spatial heterogeneity of infiltrating T cells in high-grade serous ovarian cancer revealed by multi-omics analysis
por: Yang, Bin, et al.
Publicado: (2022)

Nucleotide Excision Repair in Caenorhabditis elegans
por: Lans, Hannes, et al.
Publicado: (2011)

Clinical Implications of DNA Repair Defects in High-Grade Serous Ovarian Carcinomas
por: Milanesio, Michela Camilla, et al.
Publicado: (2020)

A novel glycolysis-related gene signature for predicting the prognosis of multiple myeloma
por: Zhang, Bingxin, et al.
Publicado: (2023)

Low-grade Serous Ovarian Carcinoma
por: Ricciardi, Enzo, et al.
Publicado: (2018)

PARP1 Inhibitor Combined With Oxaliplatin Efficiently Suppresses Oxaliplatin Resistance in Gastric Cancer-Derived Organoids via Homologous Recombination and the Base Excision Repair Pathway
por: Li, Huafu, et al.
Publicado: (2021)

Identification of EMT-Related Genes and Prognostic Signature With Significant Implications on Biological Properties and Oncology Treatment of Lower Grade Gliomas
por: Wu, Jiasheng, et al.
Publicado: (2022)

‘Omics Approaches to Explore the Breast Cancer Landscape
por: Parsons, Joseph, et al.
Publicado: (2020)

Clinical Interest of Combining Transcriptomic and Genomic Signatures in High-Grade Serous Ovarian Cancer
por: Kieffer, Yann, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qiac3pees5ag9l617jfgki6fli